| Literature DB >> 29949595 |
Hai Vu-Ngoc1, Sameh Samir Elawady2, Ghaleb Muhammad Mehyar3, Amr Hesham Abdelhamid4,5, Omar Mohamed Mattar6, Oday Halhouli7, Nguyen Lam Vuong8, Citra Dewi Mohd Ali2, Ummu Helma Hassan6, Nguyen Dang Kien9, Kenji Hirayama10, Nguyen Tien Huy11,12.
Abstract
Systematic reviews and/or meta-analyses generally provide the best evidence for medical research. Authors are recommended to use flow diagrams to present the review process, allowing for better understanding among readers. However, no studies as of yet have assessed the quality of flow diagrams in systematic review/meta-analyses. Our study aims to evaluate the quality of systematic review/meta-analyses over a period of ten years, by assessing the quality of the flow diagrams, and the correlation to the methodological quality. Two hundred articles of "systematic review" and/or "meta-analysis" from January 2004 to August 2015 were randomly retrieved in Pubmed to be assessed for the flow diagram and methodological qualities. The flow diagrams were evaluated using a 16-grade scale corresponding to the four stages of PRISMA flow diagram. It composes four parts: Identification, Screening, Eligibility and Inclusion. Of the 200 articles screened, 154 articles were included and were assessed with AMSTAR checklist. Among them, 78 articles (50.6%) had the flow diagram. Over ten years, the proportion of papers with flow diagram available had been increasing significantly with regression coefficient beta = 5.649 (p = 0.002). However, the improvement in quality of the flow diagram increased slightly but not significantly (regression coefficient beta = 0.177, p = 0.133). Our analysis showed high variation in the proportion of articles that reported flow diagram components. The lowest proportions were 1% for reporting methods of duplicates removal in screening phase, followed by 6% for manual search in identification phase, 22% for number of studies for each specific/subgroup analysis, 27% for number of articles retrieved from each database, and 31% for number of studies included in qualitative analysis. The flow diagram quality was correlated with the methodological quality with the Pearson's coefficient r = 0.32 (p = 0.0039). Therefore, this review suggests that the reporting quality of flow diagram is less satisfactory, hence not maximizing the potential benefit of the flow diagrams. A guideline with standardized flow diagram is recommended to improve the quality of systematic reviews, and to enable better reader comprehension of the review process.Entities:
Mesh:
Year: 2018 PMID: 29949595 PMCID: PMC6021048 DOI: 10.1371/journal.pone.0195955
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Diagram of selecting systematic reviews for the study.
Fig 2The proportion of papers with flow diagram over ten years.
Fig 3Characteristic of all items in flow diagram and the presence of each item.
Fig 4Scatter plot of AMSTAR total score and flow diagram score.
Fig 5Trend of AMSTAR score (A) and flow diagram score (B) over ten years.
Fig 6Correlation of flow diagram score and impact factor of journals.
Adherence to PRISMA checklist of 154 systematic reviews and/or meta-analysis in two groups: With flow diagram and without flow diagram.
| Group without flow diagram | Group with flow diagram | |
|---|---|---|
| Title | 50 (65.8%) | 64 (82.1%) |
| Structured summary | 63 (82.9%) | 68 (87.2%) |
| Rationale | 75 (98.7%) | 78 (100.0%) |
| Objectives | 74 (97.4%) | 73 (93.6%) |
| Protocol and registration | 5 (6.6%) | 6 (7.7%) |
| Eligibility criteria | 70 (92.1%) | 77 (98.7%) |
| Information sources | 71 (93.4%) | 77 (98.7%) |
| Search | 58 (76.3%) | 68 (87.2%) |
| Study selection | 63 (82.9%) | 75 (96.2%) |
| Data collection process | 27 (35.5%) | 37 (47.4%) |
| Data items | 33 (43.4%) | 38 (48.7%) |
| Risk of bias in individual studies | 23 (30.3%) | 37 (47.4%) |
| Summary measures | 38 (50.0%) | 46 (59.0%) |
| Synthesis of results | 31 (40.8%) | 40 (51.3%) |
| Risk of bias across studies | 19 (25.0%) | 24 (30.8%) |
| Additional analyses | 23 (30.3%) | 23 (29.5%) |
| Study selection | 30 (39.5%) | 75 (96.2%) |
| Study characteristics | 50 (65.8%) | 72 (92.3%) |
| Risk of bias within studies | 15 (19.7%) | 37 (47.4%) |
| Results of individual studies | 39 (51.3%) | 61 (78.2%) |
| Synthesis of results | 34 (44.7%) | 43 (55.1%) |
| Risk of bias across studies | 20 (26.3%) | 25 (32.1%) |
| Additional analysis | 24 (31.6%) | 27 (34.6%) |
| Summary of evidence | 54 (71.1%) | 66 (84.6%) |
| Limitations | 30 (39.5%) | 45 (57.7%) |
| Conclusions | 64 (84.2%) | 71 (91.0%) |
| Funding | 42 (55.3%) | 42 (53.8%) |
Fig 7New flow diagram template proposed.